From Europe to the Middle East: AMS BioteQ Expands Its Global Reach, Setting New Milestones in Medical Innovation

GENE ONLINE

In November 2024, AMS BioteQ made its debut at one of the world’s largest medical exhibitions, MEDICA 2024 in Düsseldorf, Germany, while also laying the groundwork for its upcoming participation in Arab Health 2025 in Dubai, UAE. These prestigious events mark significant milestones for AMS BioteQ as the company accelerates its global expansion strategy and strengthens its presence in both the European and Middle Eastern markets.

Success at MEDICA 2024: Showcasing Cutting-Edge Medical Technologies

At MEDICA 2024, AMS BioteQ successfully introduced its innovative SIPSIP® series of advanced wound care products, engaging with healthcare professionals from across the globe. As its first foray into the European market, the exhibition provided AMS BioteQ with an ideal platform to showcase its advanced medical solutions and foster opportunities for future international collaborations.

Highlights of the SIPSIP® Product Line

1. SIPSIP Foam High-Performance Dressing: Featuring patented material structures for superior exudate absorption and moisture management, certified by TFDA, FDA, and PMDA.
2. SIPSIP Pro Deep Wound Healing Dressing: Incorporates patented substrate technology for targeted deep wound repair and enhanced tissue regeneration.
3. SIPSIP HemoSeal Hemostatic Dressing: Engineered for rapid bleeding control, ideal for emergency wound care and trauma management.
4. SIPSIP Pros Antimicrobial Smart Dressing: Designed with innovative composite materials for long-lasting antimicrobial protection, free from antibiotics and suitable for sensitive skin.

Throughout the event, AMS BioteQ’s team demonstrated the practical applications of these products, offering detailed technical explanations to healthcare professionals, and emphasizing their superior clinical performance.

Building a Strong Foundation in Europe

During MEDICA 2024, AMS BioteQ engaged with industry experts from Europe, Asia, and the Americas, initiating multiple strategic discussions. These efforts have not only solidified the company’s groundwork for entering the European market but also established pathways for future growth. AMS BioteQ aims to collaborate with regional partners to navigate EU medical device registration and regulatory processes, further expanding the reach of its SIPSIP® product line across Europe.

A Strategic Move into the Middle East: Meeting Growing Healthcare Demands

As global healthcare demands rise, the Middle East has emerged as a dynamic hub for the medical industry. AMS BioteQ is poised to seize the opportunities in this burgeoning market and will participate in the Arab Health 2025 exhibition, scheduled from January 27 to 30, 2025, in Dubai, UAE. Recognized as the largest and most influential medical trade show in the region, Arab Health attracts industry leaders and innovators from around the world.

The Middle Eastern healthcare market is experiencing rapid growth and is projected to become a global leader in the sector. With an estimated annual market value exceeding USD 35 billion and a growth rate of 7% per year, the region presents immense potential for innovative healthcare solutions. AMS BioteQ’s SIPSIP® wound care products are uniquely designed to meet these demands, offering versatile applications for emergency hemostasis, wound care, and advanced healing for complex injuries.

Entering the Middle East: Unveiling Innovation and Solutions

Arab Health will serve as a pivotal platform for AMS BioteQ to showcase its advanced technologies and medical solutions. The event, known for bringing together healthcare professionals, industry leaders, and innovators, aligns perfectly with the company’s mission to address the growing need for high-performance medical products in the Middle East. With its cutting-edge solutions, AMS BioteQ is set to play a crucial role in advancing medical technology and fostering global collaboration.

As AMS BioteQ rapidly accelerates its internationalization efforts, the company remains committed to delivering innovative and effective healthcare solutions that benefit patients worldwide.